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ABSTRACT
Marginal donors represent a poorly utilized source of organs for transplantation despite
their availability. The key is to reduce the ischemic damage in the effort to improve organ
quality. This study investigated the histologic effects after in situ perfusion of preservation
with a two-layer method compared with the classic University of Wisconsin preservation in
term of tissue integrity and number of viable exocrine cells in the rat pancreas both after
exsanguination and at 8 weeks of cryopreservation. Pancreata harvested from 60 rats were
collected using 3 methods: two-layer method following University of Wisconsin perfusion;
exsanguination; and classic University of Wisconsin perfusion/storage. In addition to
histologic analysis of collected pancreata, we analyzed the number of CK19 cells and
their viability using chi-square tests with values P  .05 considered to be significant. Rat
pancreas histology showed as University of Wisconsin in situ perfusion and preservation by
the two-layer method to be more effective to maintain the morphologic integrity of both
exocrine and endocrine tissues. There were a larger number of CK19 cells with good
viability. Moreover, the effects of oxygenation were visible in pancreas biopsies preserved
after exsanguination. In situ University of Wisconsin perfusion and preservation for 240
minutes with the two-layer method yielded greater numbers and viability of CK19 cells
even after 8 weeks of cryopreservation.
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tEFFORTS TO EXPAND THE POOL of organs avail-able for transplantation have progressively lead to
acceptance of “marginal” kidneys or “expanded criteria
donors” among geriatric, hypertensive, and even protein-
uric individuals. A marginal organ denotes a suboptimal
situation due to reduced function albeit still useful for
transplantation. To improve these adverse situations re-
quires knowledge concerning ischemic damage inherent to
the transplant process.1–7
Over the last 10 years we have been exploring techniques
for pancreas harvest using in situ perfusion to reduce ischemic
injury in small and middle-size animals. Employing in situ
perfusion we have increased the amount and quality of
purified rat pancreatic exocrine cells compared with collection
after exsanguination.8 Moreover we have demonstrated that
ischemic injury can be minimized by static oxygenation of
tissue during cold ischemia by two-layer preservation in Uni-
versity of Wisconsin (UW)/perfluorocarbons solution (two-
layer method).9,10 Previously collection had been optimized
tilizing fluorescence cell sorting to collect purified -cellprecursors from whole human adult and children pan-
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Transplantation Proceedings, 45, 1723–1728 (2013)reata.11,12 The objective of this investigation was to deter-
ine the histologic impact of TLM compared with classic UW
reservation on pancreatic tissue recovery and as secondarily
o demonstrate whether TLM perfusion increased the number
f viable exocrine cells from rat pancreas after in situ perfusion
nd 8 weeks of cryopreservation. We sought to obtain results
hat could translate to studies of reprogramming,13,14 resis-
ance, and senescence of pancreatic cells.
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Procurement and Preservation
Whole pancreata were collected from 60Wistar rats: 40 after in situ
perfusion with UW solution at 4°C (ViaSpan, Bristol-Myers Squibb -
Italy added with dexamethasone, insulin, and glutathione)15 and
0, after exsanguination. The operative procedure was approved by
ur Ethics Committee and performed in accordance with Interna-
ional Guidelines for Animal Experimentation.16
Animals were fasted for 24 hours before collection to reduce
intestinal content. The 40 pancreata collected after in situ perfu-
sion were divided into 2 groups: 20 were saved in a sterile bag with
50 mL of UW solution at 4°C (“bag ice storage”) containing UW
solution at 4°C for 240 minutes and 20, in a special container for
240 minutes in a static TLM solution (500 mL UW plus 500 mL of
oxygenated PFC). The TLM method described in our previous
work in a porcine model was adapted for the rat.9 Oxygen was
filtered through PFC for 1 hour before preservation and the
container was cooled to 4°C. Cold ischemic time (CIT) was defined
between the end of in situ perfusion and the start of pancreas
digestion.17–25 The third group of 20 pancreata collected after
exsanguination was preserved for 240 minutes in static TLM
solution. Warm ischemic time (WIT) was defined as the time
between cessation of the heartbeat and placement of the pancreas
into the preservation solution.26 Exsanguination CIT (eCIT) was
defined between placement of the pancreas into the preservation
solution and the start of pancreas digestion.
Culture and Immunostaining
After 240 minutes of storage, exocrine tissue of three groups was
separately obtained by whole pancreatic digestion using collage-
nase P (3 mg/mL; Roche) according to Gray’s method.27 The tissue
Fig 1. Percentage of CK-19 cells and viable cell induced c
Table 1. Dono
In Situ Perfusion TLM
Pancreas (n) 20
ge (mo) 2–3
eight (g), media  SEM 133.6  0.77
ancreas weight (g), mean  SEM 82.15  0.65
IT (min), mean  SEM 13.65  0.55
CIT (min), mean  SEM 241.3  1.08
T (h), mean  SEM 1344  0.31
Data expressed as mean  standard error of the mean.
TLM, two-layer method (UW perfluorocarbons solution); UW, University of Wi
CT, cryopreservation time; NS, not significant.ryopreservation (right side of graphs). UW, University of Wisconsinellet was underlayed on a discontinuous Ficoll gradient (Sigma
ldrich, Italy) at 1108, 1096, 1069, 1037 g/cm3. After 750 g
centrifugation at 4°C for 18 minutes we observed 1096/1108 and
1037/1069 layer interfaces of acinar cells and epithelial ductal cells
respectively. An aliquot of acinar cells or epithelial ductal cells was
cryopreserved for 8 weeks using 10% Dimethylsulfoxide (DMSO)
(Sigma Aldrich, Italy) using sequential reductions of temperature
before transfer into liquid nitrogen at 196°C.28–30 Fresh pellets
ere cultured for 2 weeks in Dulbecco’s Modified Eagle Medium
DMEM) media (glucose 5.6 mmol/L) with Bovine Serum Albu-
ine (BSA) (10%), L-glutamine (2 mmol/L), penicillin/streptomy-
in (200 L/mL), and fungizone (200 L/mL).31 Thereafter sus-
ended cells were harvested, while adherent cells were identified
sing immunohistochemical staining for CK-19 using rat monoclo-
al anti- cytokeratin antibodies (1:50)/goat, anti-rat immunoglob-
lin Fluorescein Isothiocyanate (FITC) (1:250; Santa Cruz Bio-
echnology, Calif, USA) as a ductal-cell marker and 4’,6-diamidino-
-phenylindole (DAPI) (1:1000). The specimens were mounted
ell-side down on glass slides with a drop of Distrene 80 -
lasticizer dibutyl phthalate- Xylene (DPX - Sigma Aldrich, Italy)
or examination using a Zeiss light microscope. Positive cells were
andomly counted on the montage of generated photographs. Cell
iability was assayed using trypan blue staining for nonviable cells.
rypsinized adherent cells were placed on a hemocytometer for
ounting. After gradual defrosting, cryopreserved cells underwent
ercoll gradient separation (Sigma Aldrich, Italy; 1063 gr/cm3) to
liminate waste products after 8 weeks, subsequently undergoing
he same culture protocol.
All data were expressed as percentages or mean values 
tandard errors of the mean. The groups were compared using
hi-square and Student t tests with values of P  .05 considered
e medium before (left side of graphs) and after 8 weeks of
aracteristics
In Situ Perfusion UW Exsanguination TLM P
20 20 Ns
2–3 2–3 Ns
134.7  1.00 132.3  0.65 Ns
83.85  0.69 83.65  0.72 Ns
14.70  0.68 13.55  0.57 Ns
243.3  0.74 240.8  1.23 Ns
1345  0.30 1345  0.46 Ns
in solution; WIT, warm ischemia time; eCIT, exsanguination cold ischemia time;ulturr Chsolution; TLM, two-layer method (UW/PFC solution).
iTLM, two-layer method; UW, University of Wisconsin Solution.
UW-TLM PRESERVATION 1725Fig 2. Whisker and box plot of CK-19 cells and viable cells in culture medium before (a, b) and after 8 weeks of cryopreservation (c, d)Table 2. Comparison of Ratio and Percentage of CK-19 and Viable Cells for Both Freshly Collected and Cryopreserved Cells
According to the Three Different Methods
Ratio of CK-19 Cells % of CK-19 Cells Ratio of Viable Cells % Viable Cells
In situ perfusion TLM 967/1006 96.2 954/1002 95.25
In situ perfusion UW 906/997 91 884/995 88.95
Exsanguination TLM 746/906 82 625/800 78.15
After 8 Wk Cryopreservation After 8 Wk Cryopreservation After 8 Wk Cryopreservation After 8 Wk Cryopreservation
In situ perfusion TLM 908/1010 90 914/1010 91
In situ perfusion UW 853/1016 84 845/990 85.95
Exsanguination TLM 588/802 74.3 579/802 72n the 3 different collection methods. UW, University of Wisconsin Solution; TLM, two-layer method (UW/perfluorocarbons solution).
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1726 GIOVIALE, DAMIANO, PULEIO ET ALsignificant. In situperfusion TLM freshly collected and 8-weeks
cryopreserved cells were compared to In situ perfusion UW, and
exsanguination group.
Histology
Pancreatic tissue samples were fixed in 10% buffered formalin for
histological analysis. Biopsies randomly collected from the pan-
creas were embedded in paraffin, sectioned at 4 m, and stained
with hematoxylin and eosin.
RESULTS
Donor characteristics of the 3 groups—in situ perfusion
TLM group, in situ perfusion UW group and exsanguina-
Fig 3. Histologic findings. (a)
Pancreas collected after exsan-
guination and stained with he-
matoxylin and eosin (H&E; orig-
inal magnification 20): clear
degeneration and diffuse vacu-
olization of cytoplasm with zy-
mogen granules; nuclei with ve-
sicular pattern due to chromatin
dispersion; islets with pro-
nounced signs of cytoplasmic
vacuolization, and (b) at 40
(original magnification). (c) Pan-
creas collected after exsangui-
nation, preserved in two-layer
method (TLM) for 240 minutes
and stained with H&E (original
magnification 20): small de-
generation where the apical
part of exocrine cells presents
eosinophil zymogen granules,
with endocrine component con-
sisting of ovoid islets whose
cells have plentiful weakly eo-
sinophil cytoplasm and nucleus
put at center, (d) at 63 (origi-
nal magnification). (e) Pancreas
collected with in situ perfusion,
preserved in TLM for 240 min-
utes and stained with H&E (orig-
inal magnification 20): initial
degeneration signs represented
from cell swelling, vacuoliza-
tion, and nonconstant zymogen
granules fusion, with nuclei in-
creased in their volume and
margination of chromatin, and
(f) at 63 (original magnifica-
ion). (g) Moderate interstitial
edema, but good cell morphol-
ogy for exocrine component,
with nuclei showing regular
chromatin pattern and homoge-
neous volume, and (h) at 63
original magnification).ion TLM group—were similar for age, body weight, pan-
reas weight, WIT or CIT and eCIT, and cryopreservation
ime (Table 1). Fig 1 and Table 2 shows a greater number
of CK19 cells with best viability of in situ perfusion
followed by TLM preservation compared with in situ per-
fusion and UW solution preservation (P  .05; Fig 2). In
itu perfusion TLM showed significantly better results in
erm of the number and viability of CK19 cells among
collected cells (P  .0001) versus exsanguination TLM or
for in situ perfusion UW versus exsanguination TLM.
Analysis of data on 8 weeks’ cryopreserved cells revealed
overlapping findings (Table 2).
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UW-TLM PRESERVATION 1727Pathologic observations (Fig 3) on biopsies from pan-
creata collected after in situ perfusion and preserved in
TLM for 240 minutes showed little interstitial edema, but
good cell morphology in the exocrine and endocrine areas.
Nuclei showed a regular chromatin distribution in homoge-
neous volumes. There was minor degeneration among cells
collected from pancreata preserved with UW, where nuclei
showed a bigger volume with chromatin margination and
vesicular aspects of tissue damage. Measurement of nuclear
diameters of pancreatic cells preserved with UW showed a
mean cell augmentation of 3 per field at higher magnifica-
tion. Comparison of pancreas cells that did not undergo
preservation showed nuclear diameter ranging from 5.3 m
o 6.5 m, and even 9.5 m, whereas the nuclei with the
iggest dimensions reached the 9.5 m of diameter. The
nitial degeneration included cell swelling, vacuolization,
nd in some cases zymogen granule fusion among pancreata
erfused with and preserved in UW (resulted overlapping
o pancreas after exsanguination and preservation in TLM).
hese results indicated that compared with UW solution
LM improved tissue health also TLM tissue retained
erves after animal exsanguination.
DISCUSSION
In situ pancreas perfusion provokes a minor ischemic
injury. Moreover, previous studies have shown that oxygen-
ation through preservation with the TLM (UW/PFC solu-
tion) reduces cold ischemic damage even when organs are
collected from non– heart-beating donors.10 Thus a combi-
nation of methods might improve pancreas preservation for
short CIT, increasing cell viability and, as a consequence,
extending the effective duration of preservation. This im-
provement might extend the donor pool to marginal organs
and improve transplant outcomes. The efficacy of TLM on
organ preservation is controversial. Oxygenation by per-
fluorocarbons has been shown to not be adequate for thick
human tissues and for longer CIT. The TLM seems to be
effective for small thickness tissues as the rat pancreas.32,33
Histologic analyses of rat pancreas comparing classic UW
perfusion/storage with UW in situ perfusion and preserva-
tion in TLM showed that oxygenation remarkably reduced
tissue necrosis maintaining good morphologic integrity of
both exocrine and endocrine tissues.
The effects of oxygenation were visible also among
pancreas biopsies after exsanguination. In situ UW perfu-
sion and preservation for 240 minutes with TLM achieved
better cell viability even after 8 weeks’ cryopreservation.
This combination could be useful where the collected cells
are to be utilized for studies on cellular resistance and
reprogramming of ductal to islet like-elements.34
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